Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Allergan plc    AGN   IE00BY9D5467

ALLERGAN PLC (AGN)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets
Most relevant news about ALLERGAN PLC
10/19 SYNDAX PHARMACEUTICALS : Expands Pipeline with Exclusive Worldwide License to Al..
10/19 ALLERGAN : Issues Investor FAQ on Federal District Court RESTASIS® Patent Decisi..
10/18 ALLERGAN : ruling casts doubt on tribal patent strategy
10/18 ALLERGAN : to Present New Data at the World Congress of Gastroenterology at ACG ..
10/18 ALLERGAN : U.S. District Court for the Eastern District of Texas Issues Adverse ..
10/17 Amneal, Impax combine to tackle generic drug pricing pressure
10/16DJALLERGAN : Loses Patent Fight in Federal Court
10/16 ALLERGAN : U.S. District Court for the Eastern District of Texas Issues Adverse ..
10/16 ALLERGAN : to Present New Data at the World Congress of Gastroenterology at ACG ..
10/16 ALLERGAN : Announces Settlement on RESTASIS 0.05% Patent Litigation with InnoPha..
10/13 ALLERGAN : to Present Data from More Than 20 Abstracts at the 2017 Fall Clinical..
10/12 ALLERGAN : Announces Settlement on RESTASIS® (Cyclosporine Ophthalmic Emulsion) ..
10/12 ALLERGAN : Announces that the FDA Accepts New Drug Application for Ulipristal Ac..
10/11 ALLERGAN : to Present Data From More Than 20 Abstracts at the 2017 Fall Clinical..
10/11 ALLERGAN : to Present New Dry Eye Data at the American Academy of Optometry Meet..
10/10 ALLERGAN : Announces that the FDA Accepts New Drug Application for Ulipristal Ac..
10/10 ALLERGAN : Generic Drugs Stock Performance Review -- Catalyst Pharma, Flexion Th..
10/09 JUDGE QUESTIONS ALLERGAN PLC (NYSE : AGN) Patent Agreement With Mohawk Tribe
10/09 ALLERGAN : to Present New Dry Eye Data at the American Academy of Optometry Meet..
10/06 ALLERGAN : To Present New Data From Its Anti-Infectives Portfolio At IDWeek 2017..
10/05 ALLERGAN : Presents Data From Seventeen Abstracts At The 2017 American Society F..
10/05 ALLERGAN : Trump to keep Obama rule curbing corporate tax inversion deals
10/05 ALLERGAN : Trump to keep Obama rule curbing corporate tax inversion deals
10/05 ALLERGAN PLC ORDINARY SHARES (NYSE : AGN)’s Botox Gets FDA Approval For Th..
10/05 ALLERGAN : FDA Approves BOTOX Cosmetic for the Temporary Improvement in the Appe..
10/04 ALLERGAN : To Present New Data From Its Anti-Infectives Portfolio At IDWeek 2017..
10/04 ALLERGAN : to Report Third Quarter 2017 Earnings and Host Conference Call and We..
10/04 ALLERGAN : FDA Accepts Supplemental New Drug Application filing for AVYCAZ
10/03 ALLERGAN : U.S. House committee launches probe of Allergan patent deal
10/03 ALLERGAN : U.S. House committee launches probe of Allergan patent deal
10/03 SHIRE PLC (ADR)(NASDAQ : SHPG) Sues Allergan Over Anti-Competitive Behavior
10/03 ALLERGAN : FDA Approves BOTOX® Cosmetic (OnabotulinumtoxinA) for the Temporary I..
10/03DJSHIRE : Files Antitrust Lawsuit Against Rival -- WSJ
10/02DJSHIRE : Alleges Allergan Blocked Drug From Medicare Contracts -- Update
10/02DJSHIRE : Alleges Allergan Blocked Drug From Medicare Contracts
10/02 ALLERGAN : FDA Accepts Supplemental New Drug Application (sNDA) filing for AVYCA..
10/02 ALLERGAN : to Report Third Quarter 2017 Earnings and Host Conference Call and We..
09/28 ALLERGAN : ACZONE Gel, 7.5% Recognized With Teen Vogue Acne Award Win
09/28 SENATORS WANT PROBE OF ALLERGAN TRAN : letter
09/28 SENATORS WANT PROBE OF ALLERGAN TRAN : letter
09/27 ALLERGAN : New Study Showcases Economic Impact of Allergan Operations on French ..
09/27 ALLERGAN : Announces Tessa Hilado Executive Vice President and Chief Financial O..
09/27 ALLERGAN : Board of Directors Authorizes New $2 Billion Share Repurchase Program..
09/26 ALLERGAN : New Data from CENTAUR Phase 2b Clinical Study Supports Continued Deve..
09/26 ALLERGAN : Receives Refusal to File Letter from FDA for Vraylar Supplemental New..
09/26 ALLERGAN : ACZONE® (dapsone) Gel, 7.5% Recognized With Teen Vogue Acne Award Win
09/25 ALLERGAN PLC (NYSE : AGN) Files An 8-K Departure of Directors or Certain Officer..
09/25 ALLERGAN : boosts shares with $2 billion buyback
09/25 ALLERGAN : New Study Showcases Economic Impact of Allergan Operations on French ..
09/25 ALLERGAN : Announces Tessa Hilado, Executive Vice President and Chief Financial ..
1  2  3  4  5  6  7  8  9  10Next
Financials ($)
Sales 2017 15 892 M
EBIT 2017 7 624 M
Net income 2017 -3 984 M
Debt 2017 24 537 M
Yield 2017 1,55%
P/E ratio 2017 -
P/E ratio 2018
EV / Sales 2017 5,50x
EV / Sales 2018 5,24x
Capitalization 62 943 M
Chart ALLERGAN PLC
Duration : Period :
Allergan plc Technical Analysis Chart | AGN | IE00BY9D5467 | 4-Traders
Technical analysis trends ALLERGAN PLC
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Average target price 241 $
Spread / Average Target 28%
EPS Revisions
Managers
NameTitle
Brenton L. Saunders Chairman, President & Chief Executive Officer
Robert A. Stewart Chief Operating Officer
Maria Teresa Hilado Chief Financial Officer
C. David Nicholson Chief Research & Development Officer
Paul M. Bisaro Director
Sector and Competitors
1st jan.Capitalization (M$)
ALLERGAN PLC-10.35%62 943
JOHNSON & JOHNSON23.60%382 202
NOVARTIS13.50%226 404
PFIZER11.58%216 886
ROCHE HOLDING LTD.5.55%207 116
MERCK AND COMPANY7.88%174 223